Taxes On Covid-Related Drugs, Equipment Are Unacceptable

Share this article Share this article
published Published on May 5, 2021   modified Modified on May 6, 2021

-NDTV

The government is taxing people who buy Covid-related medical drugs like Remdesivir and others, as well as taxing the supplements and medical grade oxygen for oxygen cylinders, with a tax as high as 12 per cent.

New Delhi: Indian and global medical experts are shocked at the Indian government making money off the sick and dying. Every expert consulted for this report said this has to stop.

A family that buys an imported oxygen concentrator still has to pay the government 12 per cent in taxes called IGST. Till May 1, this tax was 28 per cent. The reduction was announced as a relief measure. Why 12 per cent? Why not zero tax at a time like this? People who use these oxygen machines are covid patients and yet the government is actually asking them to pay taxes so that it helps government revenue. With oxygen concentrators, people may, with doctors' advice, be able to avoid hospitalization. Shouldn't a measure like this be rewarded or incentivized instead of being taxed?

Extracting revenue from ordinary people for the government budget is even more widespread - the government is taxing people who buy Covid-related medical drugs like Remdesivir and others, as well as taxing the supplements and medical grade oxygen for oxygen cylinders, with a tax as high as 12 per cent.

Global experts question why is it necessary for India to make money out of this terrible crisis - when the people of India are on their knees.

Please click here to read more.


NDTV, 5 May, 2021, https://www.ndtv.com/india-news/coronavirus-indias-taxes-on-covid-related-drugs-equipment-are-unacceptable-2429020?pfrom=home-ndtv_topscroll&fbclid=IwAR3IS2a9NxqCYl6R4qsWPe0LqI2SoLnHbH7X-DHdARmrbQfrwbh8NOzF6Jw


Related Articles

 

Write Comments

Your email address will not be published. Required fields are marked *

*

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close